Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice? (Q45042253)
Jump to navigation
Jump to search
scientific article published in June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice? |
scientific article published in June 2005 |
Statements
1 reference
Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice? (English)
1 reference
Jeffery W Kelly
1 reference
Qinghai Zhang
1 reference
1 June 2005
1 reference
1 reference
Identifiers
1 reference